News

Innovative Smokerlyzer® and NObreath® respiratory devices to be exhibited at the European Respiratory Society International Congress. Bedfont® Scientific Limited, world leaders in breath analysis, is attending the European Respiratory Society (ERS) International Congress to showcase its innovative Smokerlyzer® and NObreath®...

September sees the return to school for children after the summer holidays. While the return to routine is welcomed, it can be challenging for children with asthma. Research by Asthma + Lung UK found that in 2022/2023, there was a...

Bedfont® Scientific Limited hosted an insightful webinar, Navigating IBS: Understanding IBS symptoms, microbiome impact and the role of HMBT, with expert Gastrointestinal Physiologist, Melissa Dooley. The webinar examined IBS symptoms, their overlap with other conditions, and how hydrogen-methane breath testing...

Carbon monoxide (CO) is a harmful gas formed through incomplete combustion and is produced when smoking tobacco. Smoking kills over 8 million people a year and is one of the biggest public health threats the world has ever faced1. This...

New partnership with Medvision for Medical Services Company brings the Gastrolyzer® range to Kuwait. Bedfont® Scientific Limited, world leaders in breath analysis, is pleased to announce its collaboration with Medvision for Medical Services Company in Kuwait. Medvision, a leading distributor...

Bedfont® sponsors IFE golf day to raise vital funds for the mental health charity Young Minds. Bedfont® Scientific Limited, a local medical breath analysis device manufacturer, is thrilled to announce its sponsorship and participation in a local charity golf day...